dc.creatorPereira, Renata Freire Alves
dc.creatorGarcia, Rita de Cássia Nasser Cubel
dc.creatorAzevedo, Kátia Martins Lopes de
dc.creatorSetúbal, Sérgio
dc.creatorSiqueira, Marilda Agudo Mendonça Teixeira de
dc.creatorOliveira, Solange Artimos de
dc.date2015-06-22T12:26:39Z
dc.date2015-06-22T12:26:39Z
dc.date2014
dc.date.accessioned2023-09-26T23:20:55Z
dc.date.available2023-09-26T23:20:55Z
dc.identifierPEREIRA. Renata Freire Alves et al. Clinical features and laboratory findings of human parvovirus B19 in human immunodeficiency virus-infected patients. Mem. Inst. Oswaldo Cruz, v.109, n.2, Apr. 2014
dc.identifier0074-0276
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/10940
dc.identifier10.1590/0074-02760130312
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8889589
dc.descriptionImmunocompromised patients may develop severe chronic anaemia when infected by human parvovirus B19 (B19V). However, this is not the case in human immunodeficiency virus (HIV)-infected patients with good adherence to highly active antiretroviral treatment (HAART). In this study, we investigated the clinical evolution of five HIV-infected patients receiving HAART who had B19V infections confirmed by serum polymerase chain reaction. Four of the patients were infected with genotype 1a strains and the remaining patient was infected with a genotype 3b strain. Anaemia was detected in three of the patients, but all patients recovered without requiring immunoglobulin and/or blood transfusions. In all cases, the attending physicians did not suspect the B19V infections. There was no apparent relationship between the infecting genotype and the clinical course. In the HAART era, B19V infections in HIV-positive patients may be limited, subtle or unapparent.
dc.formatapplication/pdf
dc.languageeng
dc.publisherFundação Oswaldo Cruz
dc.rightsopen access
dc.subjectHIV
dc.subjectHuman Parvovirus B19
dc.subjectSeroconversion
dc.subjectHIV
dc.subjectSoropositividade para HIV
dc.subjectParvovirus B19 Humano
dc.titleClinical features and laboratory findings of human parvovirus B19 in human immunodeficiency virus-infected patients
dc.typeArticle


Este ítem pertenece a la siguiente institución